Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
NCT01438073
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
96
Enrollment
OTHER
Sponsor class
Conditions
Hypogonadotropic Hypogonadism
Healthy Postmenopausal Women
Agonadism
Interventions
DRUG:
kisspeptin 112-121
DRUG:
GnRH
Sponsor
Massachusetts General Hospital